Clinical Trials
15 trialsNCT06679634 2026-05-22
Retinoblastoma Phase II Expanded Access Clinical Trial
Targeted Therapy Technologies, LLC
Phase 2 Recruiting
NCT04483778 2026-04-28
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
Phase 1 Active not recruiting
NCT03016156 2026-04-14
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
St. Jude Children's Research Hospital
Phase NA Terminated
NCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
NCT05504291 2026-02-17
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Children's Oncology Group
Phase 2 Recruiting
NCT02870907 2026-01-07
RB SFCE 09
Institut Curie
Phase 2 Active not recruiting
NCT05650749 2025-12-29
GPC2
Children's Hospital of Philadelphia
Phase 1 Recruiting
NCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT02866136 2025-11-24
RETINO2011
Institut Curie
Phase 2 Active not recruiting
NCT03618381 2025-11-20
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
Phase 1 Active not recruiting
NCT04344652 2025-09-26
Photoscreening for Retinoblastoma
Phoenix Children's Hospital
Phase NA Withdrawn
NCT03026998 2025-09-15
DepiSCARRH
Institut Curie
Phase NA Active not recruiting
NCT00186888 2025-09-04
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
St. Jude Children's Research Hospital
Phase 3 Completed
NCT04040205 2025-07-20
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Medical College of Wisconsin
Phase 2 Recruiting
NCT06424301 2025-06-26
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting